NCT05984017RecruitingNot Applicable
A Non-interventional Study and Its Clinical Relevance With Advanced Lung Squamous Cell Carcinoma
Hunan Province Tumor Hospital1 site in 1 country130 target enrollmentStarted: July 1, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 130
- Locations
- 1
- Primary Endpoint
- progression-free survival
Study Overview
Brief Summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients must be ≥18 years.
- •Provision of fully informed consent prior to any study specific procedures.
- •Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology.
- •According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
progression-free survival
Time Frame: 2 years
From registration onto that step until death, or censored at the date of last contact.
Overall survival
Time Frame: 2 years
From registration onto that step until death, or censored at the date of last contact.
Secondary Outcomes
No secondary outcomes reported
Investigators
Yongchang Zhang
Professor, Deputy Director of Thoracic Oncology Department
Hunan Province Tumor Hospital
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung CancerNSCLCNCT05991193Hunan Province Tumor Hospital100
Completed
Not Applicable
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron OverloadChronic Iron OverloadNCT05440487Novartis Pharmaceuticals489
Completed
Not Applicable
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With BicalutamideAdvanced Prostate CancerNCT00871585AstraZeneca340
Recruiting
Not Applicable
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United KingdomChronic Lymphocytic Leukemia, CLLNCT05557695AstraZeneca287
Recruiting
Not Applicable
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally AdvancedNSCLC, Stage IIINSCLC, Stage INon-small Cell Lung CancerNSCLCNCT06467383MSD Italia S.r.l.600